Foot and Mouth Disease: a Revised Policy Is Required

Por Bayry, Jagadeesh, Kaveri, Srini V.
Publicado em 2001

Foreword

Por Jolles, S, Kaveri, S V, Orange, J
Publicado em 2009

Current understanding and future directions

Por Jolles, S, Kaveri, S V, Orange, J
Publicado em 2009

Human anti-phosphorylcholine antibodies share idiotopes and are self-binding.

Por Halpern, R, Kaveri, S V, Köhler, H
Publicado em 1991

Immunomodulating effects of intravenous immunoglobulin in autoimmune and inflammatory diseases.

Por Kaveri, S V, Mouthon, L, Kazatchkine, M D
Publicado em 1994

Treatment of autoimmune diseases with normal immunoglobulin through manipulation of the idiotypic network.

Por Ronda, N, Kaveri, S V, Kazatchkine, M D
Publicado em 1993

Intravenous immunoglobulin expands regulatory T cells in autoimmune rheumatic disease

Por Bayry, Jagadeesh, Mouthon, Luc, Kaveri, Srini V.
Publicado em 2012

Th17 cells, pathogenic or not? TGF-β3 imposes the embargo

Por Sharma, Meenu, Kaveri, Srini V, Bayry, Jagadeesh
Publicado em 2013

Intravenous immunoglobulin as clinical immune-modulating therapy

Por Gilardin, Laurent, Bayry, Jagadeesh, Kaveri, Srini V.
Publicado no CMAJ (2015)

Cross-presentation of antigens by dendritic cells: role of autophagy

Por Das, Mrinmoy, Kaveri, Srini V., Bayry, Jagadeesh
Publicado no Oncotarget (2015)

The Homophilic Domain – An Immunological Archetype

Por Kohler, Heinz, Bayry, Jagadeesh, Kaveri, Srinivas V.
Publicado no Front Immunol (2016)

Induction of human dendritic cell maturation by naïve and memory B-cell subsets requires different activation stimuli

Por Maddur, Mohan S., Kaveri, Srini V., Bayry, Jagadeesh
Publicado no Cell Mol Immunol (2018)

Intravenous immunoglobulin immunotherapy for coronavirus disease‐19 (COVID‐19)

Por Galeotti, Caroline, Kaveri, Srini V, Bayry, Jagadeesh
Publicado no Clin Transl Immunology (2020)

Natural IgM in immune equilibrium and harnessing their therapeutic potential

Por Kaveri, Srini V., Silverman, Gregg J., Bayry, Jagadeesh
Publicado em 2012

Impaired regulatory T cell function in autoimmune diseases: are microRNAs the culprits?

Por Sharma, Varun K, Kaveri, Srini V, Bayry, Jagadeesh
Publicado no Cell Mol Immunol (2016)

Intravenous immunoglobulins (IVIg) in the treatment of autoimmune diseases.

Por Kaveri, S V, Dietrich, G, Hurez, V, Kazatchkine, M D
Publicado em 1991

Effect of CC chemokine receptor 4 antagonism on the evolution of experimental autoimmune encephalomyelitis

Por Othy, Shivashankar, Topçu, Selma, Kaveri, Srini V., Bayry, Jagadeesh
Publicado em 2012

DC-SIGN and α2,6-sialylated IgG Fc interaction is dispensable for the anti-inflammatory activity of IVIg on human dendritic cells

Por Bayry, Jagadeesh, Bansal, Kushagra, Kazatchkine, Michel D., Kaveri, Srini V.
Publicado em 2009

Intravenous immunoglobulins in immunodeficiencies: more than mere replacement therapy

Por Kaveri, S V, Maddur, M S, Hegde, P, Lacroix-Desmazes, S, Bayry, J
Publicado em 2011

Kawasaki disease: Aetiopathogenesis and therapeutic utility of intravenous immunoglobulin

Por Galeotti, Caroline, Bayry, Jagedeesh, Kone-Paut, Isabelle, Kaveri, Srinivas V.
Publicado no Autoimmun Rev (2010)